![Sohanya Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sohanya Cheng
Corporate Officer/Principal bij
KARYOPHARM THERAPEUTICS INC.
Vermogen: 207 245 $ op 31-07-2026
Profiel
Sohanya Cheng is currently Chief Commercial Officer at Karyopharm Therapeutics, Inc. since 2021.
Former positions include Independent Director at Carisma Therapeutics, Inc. from 2024 to 2025, VP, Head-Marketing & Corporate Affairs at Arrowhead Pharmaceuticals, Inc. in 2020, and Executive Director & Head-National Sales Force at Amgen, Inc. from 2019 to 2020.
Education includes undergraduate and graduate degrees from the University of Cambridge and an MBA from MIT Sloan School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-05-2026 | 107.940 ( 0,48% ) | 207 245 $ | 31-07-2026 | |
| 31-05-2025 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Sohanya Cheng
| Bedrijven | Functie | Begin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 10-01-2022 |
Eerdere bekende functies van Sohanya Cheng
| Bedrijven | Functie | Einde |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur/Bestuurslid | 31-12-2025 |
| ARROWHEAD PHARMACEUTICALS, INC. | Verkoop & Marketing | 01-12-2020 |
| AMGEN INC. | Verkoop & Marketing | 01-08-2020 |
Opleiding van Sohanya Cheng
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
